Our top pick for
Lianluo Smart Limited is a medical devices business based in the US. Lianluo Smart shares (LLIT) are listed on the NASDAQ and all prices are listed in US Dollars. Lianluo Smart employs 28 staff and has a trailing 12-month revenue of around USD$480,420.
|52-week range||USD$2.56 - USD$11.99|
|50-day moving average||USD$6.8956|
|200-day moving average||USD$4.6096|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.51|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|Gross profit TTM||USD$-360,286|
|Return on assets TTM||-29.27%|
|Return on equity TTM||-142.66%|
|Market capitalisation||USD$42 million|
TTM: trailing 12 months
There are currently 321,930 Lianluo Smart shares held short by investors – that's known as Lianluo Smart's "short interest". This figure is 20.5% up from 267,065 last month.
There are a few different ways that this level of interest in shorting Lianluo Smart shares can be evaluated.
Lianluo Smart's "short interest ratio" (SIR) is the quantity of Lianluo Smart shares currently shorted divided by the average quantity of Lianluo Smart shares traded daily (recently around 1.5 million). Lianluo Smart's SIR currently stands at 0.22. In other words for every 100,000 Lianluo Smart shares traded daily on the market, roughly 220 shares are currently held short.
However Lianluo Smart's short interest can also be evaluated against the total number of Lianluo Smart shares, or, against the total number of tradable Lianluo Smart shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Lianluo Smart's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Lianluo Smart shares in existence, roughly 90 shares are currently held short) or 0.1651% of the tradable shares (for every 100,000 tradable Lianluo Smart shares, roughly 165 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Lianluo Smart.
Find out more about how you can short Lianluo Smart stock.
We're not expecting Lianluo Smart to pay a dividend over the next 12 months.
Lianluo Smart's shares were split on a 1:8 basis on 26 October 2020. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Lianluo Smart shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Lianluo Smart shares which in turn could have impacted Lianluo Smart's share price.
Over the last 12 months, Lianluo Smart's shares have ranged in value from as little as $2.56 up to $11.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lianluo Smart's is -0.1868. This would suggest that Lianluo Smart's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Lianluo Smart has bucked the trend.
Lianluo Smart Limited, together with its subsidiaries, designs, develops, markets, and distributes medical products and medical components primarily in China and internationally. The company offers medical devices, including wearable sleep respiratory solutions, general hospital products, medical compressors, and related supporting products. It also provides technical services in relation to the detection and analysis of obstructive sleep apnea syndrome to hospitals and medical centers through medical wearable devices. In addition, the company distributes medical products, such as sleep apnea machines, ventilator air compressors, and laryngoscope. Lianluo Smart Limited sells its products primarily through distributors; and directly to hospitals, physical examination centers, insurance companies, and governmental agencies, as well as to individual consumers. The company was formerly known as Dehaier Medical Systems Limited and changed its name to Lianluo Smart Limited in November 2016. Lianluo Smart Limited was founded in 2003 and is headquartered in Beijing, China.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.